TG8-260
TG8-260 is a potent and orally bioavailable EP2 receptor antagonist developed for research on neuroinflammatory and peripheral inflammatory diseases. It demonstrates efficacy in reducing gliosis and inflammation in rodent seizure models and inhibits pro-inflammatory gene expression in microglial cell assays, supporting its use in both in vivo and in vitro anti-inflammatory pathway studies.
Product Specifications
CAS Number
2490544-50-6
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.02% (May vary between batches)
Smiles
O=C (NCCC=1C=2C=CC=CC2NC1C) C=3C=CC (=CC3) C4=CN=CN4
Molecular Formula
C21H20N4O
Molecular Weight
344.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC206184L4V 200 µL
KHDC1 (NM_030568) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 135615-ML650 100 µL
ZNF18 (Zinc Finger Protein 18, Heart Development-specific Gene 1 Protein, HDSG1, Zinc Finger Protein 535, ZNF535, Zinc Finger Protein KOX11, KOX11, Zinc Finger Protein with KRAB and SCAN Domains 6, ZKSCAN6) (MaxLight 650)
Sign In for Pricing
View Details